Loading...
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
IMPORTANCE: Risk of developing progressive multifocal leukoencephalopathy (PML) is the major barrier to using natalizumab for patients with multiple sclerosis (MS). To date, the association of risk stratification with PML incidence has not been evaluated. OBJECTIVE: To describe the temporal evolutio...
Saved in:
| Published in: | JAMA Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Medical Association
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6724170/ https://ncbi.nlm.nih.gov/pubmed/31479149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.2670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|